Key to long-term value: discipline, execution and consistent communication.

Print pageEmail pageShare page

News releases

« Back
ARIAD to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 2, 2012-- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company’s business at two upcoming investor conferences:

  • The 14th Annual BIO CEO & Investor Conference in New York City. Dr. Berger’s presentation is on Monday, February 13 at 9:00 a.m. (ET)
  • The Leerink Swann 2012 Global Healthcare Conference in New York City. Dr. Berger’s presentation is on Wednesday February 15 at 3:30 p.m. (ET)

Both presentations will be webcast live and can be accessed by visiting the investor relations section of the Company's website at A replay of the presentation will also be available and archived on the site for three weeks.


ARIAD Pharmaceuticals, Inc. is an emerging global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. ARIAD’s approach to structure-based drug design has led to three internally discovered, molecularly targeted product candidates for drug-resistant and difficult-to-treat cancers, including certain forms of chronic myeloid leukemia, soft tissue and bone sarcomas and non-small cell lung cancer. For additional information, visit

Source: ARIAD Pharmaceuticals, Inc.

ARIAD Pharmaceuticals, Inc.
For Investors
Maria E. Cantor, 617-621-2208
For Media
Liza Heapes, 617-621-2315